Landmarks Berhad:戦略・SWOT・企業財務分析

◆英語タイトル:Landmarks Berhad - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015267
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Landmarks Berhad – Strategy, SWOT and Corporate Finance Report
Summary

Landmarks Berhad – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Landmarks Berhad (Landmarks) is an investment holding company. The company, through its subsidiaries, is involved in the hospitality and property investment businesses. Landmarks operates hotels and resorts, and is also focused on property development, wellness and spa, and township development business. It operates hotels under the brands of The Andaman and V Integrated Wellness (VIW) and Treasure Bay. Landmarks’ hotels are equipped with the lobby lounge, and live entertainment facilities. It also offers construction, marketing, civil engineering, project financing, consultancy services and rubber and oil palm plantations. The company operates through its subsidiaries across Malaysia, Australia, Indonesia, Singapore and Republic of Seychelles. Landmarks is headquartered in Kuala Lumpur, Malaysia.

Scope

- Detailed information on Landmarks Berhad required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Landmarks Berhad in the form of a SWOT analysis
- An in-depth view of the business model of Landmarks Berhad including a breakdown and examination of key business segments
- Intelligence on Landmarks Berhad’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Landmarks Berhad, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Landmarks Berhad and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Landmarks Berhad as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Landmarks Berhad’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Landmarks Berhad: Company Overview
Landmarks Berhad: Overview and Key Facts
Landmarks Berhad: Overview
Landmarks Berhad: Key Facts
Landmarks Berhad: Key Employees
Landmarks Berhad: Key Employee Biographies
Landmarks Berhad: Major Products and Services
Landmarks Berhad: Company History
Landmarks Berhad: Management Statement
Landmarks Berhad: Locations and Subsidiaries
Landmarks Berhad: Key Competitors
Landmarks Berhad: Company Analysis
Landmarks Berhad: Business Description
Landmarks Berhad: SWOT Analysis
Landmarks Berhad: SWOT Overview
Landmarks Berhad: Strengths
Landmarks Berhad: Weaknesses
Landmarks Berhad: Opportunities
Landmarks Berhad: Threats
Landmarks Berhad: Corporate Financial Deals Activity
Landmarks Berhad: Financial Deals Overview
Landmarks Berhad: Top Deals 2013 – 2017YTD*
Landmarks Berhad: Capital Raising
Landmarks Berhad: Recent Developments
Landmarks Berhad: News and Events Summary
Landmarks Berhad: Corporate Governance
Landmarks Berhad: Financial Performance
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Landmarks Berhad: Key Facts
Table 2: Landmarks Berhad: Key Employees
Table 3: Landmarks Berhad: Locations and Subsidiaries
Table 4: Landmarks Berhad: Key Competitors
Table 5: Landmarks Berhad: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Landmarks Berhad: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: Landmarks Berhad: Top Deals 2013 - 2017YTD*
Table 8: Landmarks Berhad: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 9: Landmarks Berhad: Capital Raising by Deal Type (2013 - YTD*2017)
Table 10: Landmarks Berhad: News and Events Summary
Table 11: Landmarks Berhad: Corporate Governance
Table 12: Landmarks Berhad: Financial Performance

★海外企業調査レポート[Landmarks Berhad:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mitsubishi Chemical Holdings Corporation:戦略・SWOT・企業財務分析
    Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Children’s Medical Center:企業の戦略的SWOT分析
    Children's Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ryosan Company, Ltd:企業の戦略・SWOT・財務分析
    Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report Summary Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Aurinia Pharmaceuticals Inc (AUP):企業の財務・戦略的SWOT分析
    Summary Aurinia Pharmaceuticals Inc (Aurinia Pharmaceuticals), formerly known as Isotechnika Pharma Inc, develops and commercialization of therapies. The company pipeline product Voclosporin, is used for the treatment of lupus nephritis (LN) and focal segmental glomerularsclerosis (FSGS); and voclos …
  • The Real Good Food Company plc:戦略・SWOT・企業財務分析
    The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report Summary The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Deutsche Bundesbank:企業の戦略的SWOT分析
    Deutsche Bundesbank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Orange SA (ORA):企業の財務・戦略的SWOT分析
    Orange SA (ORA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Simon Property Group, Inc.:企業の戦略・SWOT・財務情報
    Simon Property Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Simon Property Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Power Finance Corp Ltd (PFC):企業の財務・戦略的SWOT分析
    Power Finance Corp Ltd (PFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Greif, Inc.:戦略・SWOT・企業財務分析
    Greif, Inc. - Strategy, SWOT and Corporate Finance Report Summary Greif, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Sahara Petrochemicals Co:企業の戦略的SWOT分析
    Sahara Petrochemicals Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • C-TRI Co Ltd (047920):製薬・医療:M&Aディール及び事業提携情報
    Summary C-TRI Co Ltd (C-TRI), a subsidiary of DAE HWA Pharmaceutical Co Ltd, is a pharmaceutical company that offers development of new peptide drugs. The company’s products include ethicals, over-the-counter drugs, Quasi-drugs, cosmetics, amendments, pharmaceuticals, taltirelin, desmopressin, presc …
  • Turkiye Petrol Rafinerileri AS (TUPRS):石油・ガス:M&Aディール及び事業提携情報
    Summary Turkiye Petrol Rafinerileri AS (Tupras), a subsidiary of Enerji Yatirimlari AS, is a downstream energy company. It refines crude oil and marketing of petroleum products. The company operates refineries in Izmit, Izmir, Kirikkale and Batman, and is mainly active in Turkey. Tupras’s refineries …
  • Collegium Pharmaceutical Inc (COLL)-医療機器分野:企業M&A・提携分析
    Summary Collegium Pharmaceutical Inc (Collegium) is a healthcare products provider that develops chronic pain and oral drug delivery solutions. The company's lead candidate, Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone that uses DETERx technology for the long-te …
  • Syndax Pharmaceuticals Inc (SNDX):企業の財務・戦略的SWOT分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is a biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate includes entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for the tre …
  • New Gold Inc
    New Gold Inc - Strategy, SWOT and Corporate Finance Report Summary New Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Clark Public Utilities:発電所・企業SWOT分析
    Clark Public Utilities – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …
  • Taikisha Ltd:企業の戦略・SWOT・財務分析
    Taikisha Ltd - Strategy, SWOT and Corporate Finance Report Summary Taikisha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • GraceKennedy Ltd (GK):企業の財務・戦略的SWOT分析
    GraceKennedy Ltd (GK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Micromem Technologies Inc (MRM):企業の財務・戦略的SWOT分析
    Summary Micromem Technologies Inc (Micromem) operates as a technology company that develops and markets magnetic sensor products. The company designs and develops sensors specific to industrial requirements. It offers solutions such as nanoparticle detection solutions, structural integrity sensors, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆